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ABSTRACT
Background: Antibiotic associated diarrhea (AAD) occurs from the first initiation until 2 months of the end 
of antibiotic treatment. The aims of this study were to know the incidence of AAD, Clostridium difficile infection 
and other gastrointestinal symptoms in hospitalized adult patients.
Method: The study is a cross sectional study. We studied the antibiotic associated diarrhea (AAD), Clostridium 
difficile infection and other gastrointestinal symptoms in patients who were admited in Cipto Mangunkusumo 
Hospital. Inclusion were male or female, age 18-75 years old, patients started receiving antibiotics maximal 2 
x 24 hours prior to hospitalization, gave written informed consent. 
Results: The incidence of AAD was 11.5%. The incidence of Clostridium difficile infection was 15.4%. The 
upper gastrointestinal symptom was present on 20 (38.5%) patients. Lower abdominal symptom was present 
on 10 (19.2%) patients.
Conclusion: The Incidence of AAD and Clostridium difficile infection were 11.5% and 15.4% respectively. 
The clinical manifestations of AAD were diarrhea, other upper and lower abdominal symptoms. 
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ABSTRAK
Latar belakang: Diare akibat antibiotik (DAA) terjadi sejak awal sampai 2 bulan setelah pengobatan 
antibiotik. Tujuan penelitian ini adalah untuk mengetahui insiden DAA, infeksi Clostridium difficile, dan gejala 
gastrointestinal lainnya pada pasien dewasa yang dirawat di rumah sakit.
Metode: Penelitian ini merupakan penelitian potong lintang. Kami meneliti diare akibat antibiotik (DAA), 
infeksi Clostridium difficile, dan gejala gastrointestinal lainnya pada pasien yang dirawat di Rumah Sakit Cipto 
Mangunkusumo. Inklusi adalah laki-laki atau perempuan usia 18-75 tahun. Pasien mulai menerima antibiotik 
maksimal 2 x 24 jam sebelum dirawat di rumah sakit, memberikan informed consent tertulis.
Hasil: Insiden DAA adalah 11.5%. Kejadian infeksi Clostridium difficile adalah 15.4%. Gejala saluran 
gastrointestinal atas terjadi pada 20 (38.5%) pasien. Gejala gastrointestinal bawah terjadi pada 10 (19.2%) 
pasien.
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Simpulan: Insiden DAA dan infeksi Clostridium difficile masing-masing 11.5% dan 15.4%. Manifestasi klinis 
DAA yaitu diare, gejala gastrointestinal atas, bawah, dan lainnya. 
 
Kata kunci: insiden, diare akibat antibiotik (DAA), Clostridium difficile
INTRODUCTION
 Antibiotic associated diarrhea (AAD) occurs 
from the first initiation until 2 months of the end 
of antibiotic treatment.1,2 The prevalence of AAD 
is estimated 10 to 15% of all hospitalized patients 
treated with antibiotics.3 Almost any antibiotic can 
cause an imbalance of bacteria in the body, and cause 
gastrointestinal symptoms with or without diarrhea. 
Clostridium difficile (CD) toxins can be found in the 
stool of 15-25% patients with AAD and more than 95% 
of patients manifested as pseudomembranous colitis.4,5 
 Risk factors of Clostridium difficile infection are 
age above 65 years old, hospitalization, antibiotics 
treatment, severe underlying illness, nasogastric 
intubation, antiulcer medications, receive multiple 
antimicrobial agents and undergo a longer course 
of therapy.6 The clinical manifestation of antibiotic 
associated diarrhea or CD associated diarrhea may vary 
from mild diarrhea to fulminant colitis.6
 The treatment of AAD or CD associated diarhea 
include non-pharmacologic, pharmacologic including 
antibiotics (metronidazole, vancomycine, fidaxomicin), 
probiotics and surgery.3,7-12 The aims of this study is 
to know the incidence of AAD, Clostridium difficile 
infection and other gastrointestinal symptoms in 
hospitalized adult patients. 
METHOD
 This study was a cross sectional study. We studied 
the antibiotic associated diarrhea (AAD) and other 
gastrointestinal symptoms in patients with antibiotic 
treatment who were admited in Cipto Mangunkusumo 
Hospital 2010-2013.
 Diagnosis AAD was made if > 3 abnormal loose 
bowel movement and 3 unformed stool in 24 hours for a 
minimum 2 days, and occur from initiation to 2 months 
end of antimicrobial treatment (mostly 2 weeks). Other 
gastrointestinal symptoms were recorded such as upper 
gastrointestinal symptoms (nausea, vomiting, bloating, 
epigastric pain), and lower gastrointestinal symptoms 
(abdominal pain, constipation, and flatulence). 
Clostridium difficile infection was examined with the 
stool’s test of Clostridium difficile’s toxin (toxin A & 
B) using Enzyme immunoassay (EIA) tests.1,3,5
 The SPSS 12 software was used for the statistical 
analysis. The inclusion criteria were male or female, age 
18-75 years old, patients started receiving antibiotics 
maximal 2 x 24 hours prior to hospitalization, gave 
written informed consent. The exclusion criteria were 
diarrhea symptoms during admission and maximal 
7 days prior to hospitalization, receiving antibiotic 
2 weeks prior to hospitalization, pregnant women, 
non-reassuring vital sign (severe condition, worse 
condition, shock), non-functioning gastrointestinal 
tract (severe vomiting, acute pancreatitis), severe 
immunocompromised patients: chemotheraphy, HIV 
(+) and AIDS. 
RESULTS
 The characteristics of patients in this study could 
bee seen in Table 1. The most frequent characteristic 
of the patients was male (59.6%), age 48.9 + 16.5 
years old, respiratory tract infection (35.1%) and using 
Cephalosporin antibiotic (90.4%). 
Table 1. Patient’s characteristics
Variable n (%)
Sex
 Male
 Female
31 (59.6)
21 (40.4))
Age (mean + SD) year 48.9 + 16.5
Respiratory tract infection 18 (35.1)
Antibiotic types
Cephalosporin
Non-cephalosporin
47 (90.4)
5 (9.6)
The incidence of antibiotic associate diarrhea (AAD) 
was 6 (11.5%). The Clostridium difficile total incidence 
in both groups was 8 (15.4%) (see Table 2, Table 3).
AAD (+) AAD (-)
AAD (+) AAD (-)
Figure 1. Incidence of antibiotic associated 
diarrhea (AAD)
Table 2. Incidence of antibiotic associated diarrhea (AAD) 
AAD n (%)
Yes 6 (11.5)
No 46 (88.5)
AAD: antibiotic associated diarrhea
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AAD was present on 6 patients (11.5%). Clostridium 
difficile was present on 8 patients (15.4%). Upper 
gastrointestinal symptoms were present on 20 (38.5%) 
patients. Lower gastrointestinal symptoms were present 
on 10 (19.2%) patients. The upper gastrointestinal 
symptoms included nausea, vomitus, epigastric pain 
& bloating. The lower abdominal symptoms included 
abdominal pain, constipation & flatulence. 
CONCLUSION
 The Incidence of AAD and Clostridium difficile 
infection were 11.5%. and 15.4% respectively. The 
clinical manifestations of AAD were diarrhea, other 
upper and lower gastrointestinal symptoms. 
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Table 3. Incidence of of antibiotic associated diarrhea (AAD) 
and other characteristics
Variable 
(total n = 52) n (%)
AAD 6 (11.5)
C.Difficile infection 8 (15.4)
Upper gastrointestinal symptoms 20 (38.5)
Lower abdominal symptoms 10 (19.2)
Mean duration using antibiotic 16.41 ± 28,52
Mean length of hospital stay 12.79 ± 9.37
AAD: antibiotic associated diarrhea
DISCUSSION
 The most frequent sex of the patients in this study 
was men, and most patients suffered respiratory tract 
infection. This result was inline with the result of 
Elseviers MM’ study which also revealed that the 
largest characteristic in the study was also men (52%) 
and in about half of the patients have respiratory tract 
infection as the indication for antibiotic treatment.13 
Age of patients receiving antibiotics in this study had 
mean age of 48.9 + 16.5 years old, somewhat different 
from the study of Elseviers MM which found that 
the average age of the patients was 68 (range 16-99) 
years old.13
 The incidence of AAD in this study (11.5%) is 
almost equal to the AAD prevalence of Elseviers 
MM’s research which revealed 9.6%.13 AAD in this 
study was more related to the use of cephalosporin, 
this is different if compared to the Elseviers MM’s 
study, in which the most frequent antibiotics used 
were penicillin.13
In this study, a total of Clostridium difficile infection 
in both groups was15.4%, this is in accordance with the 
results of other studies.13 In this study, beside diarrhea 
there were also other clinical manifestations such as 
upper and lower gastrointestinal symptoms. Lower 
gastrointestinal symptoms that patients complained 
were abdominal pain, constipation & flatulence, 
diarrhea. This was similar to the results of other studies 
which found the AAD symptoms such as watery 
diarhea, abdominal cramping, abdominal tenderness 
and pain, blood or pus in bowel movements, fever, 
nausea, loss of appetite and dehydration.14
